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Abstract
Background: Current accelerometer technology allows for data collection using brief time sampling intervals (i.e., 
epochs). The study aims were to examine the role of epoch length on physical activity estimates and subsequent 
relationships with clinically-meaningful health outcomes in post-menopausal women.
Methods: Data was obtained from the Woman On the Move through Activity and Nutrition Study (n = 102). 
Differences in activity estimates presented as 60s and 10s epochs were evaluated using paired t-tests. Relationships 
with health outcomes were examined using correlational and regression analyses to evaluate differences by epoch 
length.
Results: Inactivity, moderate- and vigorous-intensity activity (MVPA) were significantly higher and light-intensity 
activity was significantly lower (all P < 0.001) when presented as 10s epochs. The correlation between inactivity and 
self-reported physical activity was stronger with 10s estimates (P < 0.03); however, the regression slopes were not 
significantly different. Conversely, relationships between MVPA and body weight, BMI, whole body and trunk lean and 
fat mass, and femoral neck bone mineral density was stronger with 60s estimates (all P < 0.05); however, regression 
slopes were similar.
Conclusion: These findings suggest that although the use of a shorter time sampling interval may suggestively reduce 
misclassification error of physical activity estimates, associations with health outcomes did not yield strikingly different 
results. Additional studies are needed to further our understanding of the ways in which epoch length contributes to 
the ascertainment of physical activity in research studies.
Trial Registration: Clinical Trials Identifier: NCT00023543
Background
Waist-worn accelerometers provide a reliable and valid
objective measure of free-living physical activity[1].
Accelerometers have been used in many research applica-
tions including validation of self-report physical activity
measures, identification of psychosocial and environ-
mental correlates of physical activity behavior, quantifica-
tion of physical activity to examine relationships with
health outcomes, measurement of physical activity levels
within a population-based surveillance system [i.e.,
National Health and Nutrition Examination Survey
(NHANES)], and evaluation of the success of physical
activity or lifestyle interventions [1-3]. As accelerometers
become increasingly more popular to ascertain physical
activity levels in research settings, further development
and refinement of methodologies related to data reduc-
tion and analyses are needed.
Many accelerometers function by integrating a filtered
acceleration signal over a user-defined time sampling
interval, which is commonly referred to as an epoch. At
* Correspondence: Kelley.P.Gabriel@uth.tmc.edu
1 Division of Epidemiology and Disease Control; University of Texas Health 
Science Center; Austin, TX 78701, USA
Full list of author information is available at the end of the article© 2010 Gabriel et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Gabriel et al. International Journal of Behavioral Nutrition and Physical Activity
2010, 7:53
Page 2 of 10the end of each epoch, the summed value (i.e., activity
count) is stored in the monitor memory[4]; this process is
repeated until data collection is complete. First genera-
tion accelerometers had limited data storage capabilities;
therefore, research applications that required continuous
data collection over an extended period of time (i.e., 7
days) were limited to the use of a 60s (second) epoch.
Technological advancements have increased the memory
capacity of accelerometers, which permit researchers to
make use of a shorter time sampling interval. However,
the benefit of utilizing a shorter time sampling interval
when compared to collecting physical activity data using
the more conventional 60s epoch is not fully under-
stood[5].
To date, much of the accelerometer-based research that
utilized shorter epoch intervals has been done in chil-
dren. When compared with adults, children tend to
engage in frequent bursts of moderate- to vigorous-
intensity physical activity (MVPA) that last over a rela-
tively short period of time[6,7]. Therefore, capturing this
pattern of frequent, high-intensity, short duration physi-
cal activity is optimized with a shorter sampling interval.
If the traditional 60s epoch was used in children, shorter
bursts of MVPA would simply be averaged over the min-
ute and would likely go undetected[4]. Regardless of age,
the imprecise detection of true physical activity levels
increases the risk for non-differential misclassification,
which can result in a reduction in the strength of associa-
tion between physical activity and health outcomes of
interest.
Little is known about the role of epoch length on adult
estimates of physical activity[4]. It is intuitive that captur-
ing activity in shorter epochs would result in a more pre-
cise measurement of overall physical activity. However, it
is unknown whether this level of precision will signifi-
cantly enhance our understanding of the association
between measured physical activity and health outcomes.
Therefore, the objectives of the current study are to: 1)
compare physical activity estimates collected over shorter
epoch intervals (i.e., 10s) with physical activity estimates
that were generated using traditional time sampling inter-
vals (i.e., 60s) and 2) examine whether physical activity
data presented as 10s, rather than 60s epochs, improved
the ability to evaluate physical activity-health outcome
relationships. These objectives were examined using
cross-sectional data from the 48 month follow-up visit of
the Woman On the Move through Activity and Nutrition
(WOMAN) Study, a randomized clinical trial of primary
cardiovascular disease (CVD) prevention in overweight,
post-menopausal women. In women, the risk of chronic
disease increases exponentially as they transition through
menopause[8-10]; therefore, examining the role of epoch
length on health outcomes that are common among this
population sub-group is imperative to inform best prac-
tices for prevention. Accelerometer data was collected
using 10s epoch in order to utilize data processing meth-
ods that were available during the time of the 48 month
visit.
Methods
Study participants and design
The WOMAN Study was designed to evaluate the effec-
tiveness of a non-pharmacological lifestyle intervention
focused on weight loss through dietary and physical
activity changes to reduce measures of sub-clinical ath-
erosclerosis among early postmenopausal women aged
52-62 years. The study design of the WOMAN Study,
including a description of the health education and life-
style change groups has been previously reported[11].
Briefly, eligibility criteria for study enrollment included
body mass index (BMI) between 25-39.9 kg/m2, average
waist circumference (WC) ≥80 cm, no diagnosed CVD,
type 2 diabetes mellitus, or psychotic disorder including
depression, blood pressure ≤ 140/90 mmHg with or with-
out antihypertensive therapy, low density lipoprotein
cholesterol (LDL-c) level between 100-160 mg/dL with-
out lipid lowering therapy, and completion of the 400 m
walk test. Women were recruited through direct mailing
from selected ZIP codes in Allegheny County, Pennsylva-
nia from April 2002 to October 2003. The study protocol
was approved by the institutional review board at the
University of Pittsburgh and all participants provided
written informed consent.
Participant characteristics
Age and demographic factors including race/ethnicity,
educational attainment, marital status, and health behav-
ior information were collected using standardized ques-
tionnaires. Information on medication use (i.e., hormone,
lipid lowering, antihypertensive, and hypoglycemic ther-
apy) was obtained via self-report and from a medication
inventory.
Physical activity
Accelerometer data was collected using the ActiGraph
GT1M accelerometer (Pensacola, FL). The ActiGraph
GTIM accelerometer is a small (3.8 × 3.7 × 1.8cm), uni-
axial piezoelectric activity monitor that measures acceler-
ation in the vertical plane. Data output from the Acti-
Graph accelerometer are activity counts (ct), which
quantify the amplitude and frequency of detected accel-
erations, and activity counts are summed over a user-
specified time interval (i.e., epoch). The sum of the activ-
ity counts over an epoch is related to activity intensity
and can be categorized based on validated activity count
cut-points[1,3,12]. In the current study, data were col-
lected in 10s epochs and data were reintegrated into 60s
epochs for comparison. Technical specifications, as well
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been described previously.
WOMAN Study participants were instructed to wear
the accelerometer on a belt over the hip corresponding to
their dominant hand for seven consecutive days during
all waking hours. Data from the accelerometer were
downloaded and screened for wear time using methods
reported by Troiano et al[14]. Average activity volume
(ct/min/d) was calculated using summed daily counts
detected over wear periods. Time spent per day (min/d)
in different intensity levels was estimated using threshold
values obtained from prior calibration studies and used in
the 2003-2004 NHANES analyses by Troiano et al[3]. For
classification of 10s epochs, NHANES threshold values
were multiplied by a factor of 0.17 (i.e., 10s/60s). Sum-
mary accelerometer-determined physical activity esti-
mates were averaged (per day) for all participants with at
least four valid days of 10 or more hours of wear time.
Self-reported physical activity was collected using the
past-year version of the Modifiable Activity Question-
naire (MAQ), an interviewer-administered questionnaire,
which assesses leisure and occupational activities over
the past year[15]. Due to the limited reported occupa-
tional activity in the WOMAN Study population[16],
only the leisure physical activity estimate is reported.
Physical activity levels were calculated as the product of
the duration and frequency of 39 common leisure activi-
ties (hr·wk-1), weighted by a standardized estimate of the
metabolic equivalent (MET) of each activity[17], and
then summed for all activities performed. Self-reported
leisure physical activity is expressed as metabolic equiva-
lent hours per week (MET•hr•wk-1). The MAQ has been
previously shown to be a reliable[15,18] and
valid[15,18,19] estimate of self-reported physical activity.
400 meter (w) walk
The 400 m walk test is a component of the long distance
corridor walk protocol that requires participants to walk
10 laps along a hallway with cones set 20 meters
apart[20]. Participants with elevated blood pressure (BP ≥
200/110 mmHg), resting heart rate (HR) (>110 or <40
bpm), or self-reported chest pain, shortness of breath, or
cardiac event or procedure within the past three months
were excluded for safety reasons. The 400 m walk was
stopped if the participant's HR exceeded 135 bpm or if
chest pain or dyspnea was reported. Data is expressed as
the time (s) taken to complete the 400 m distance. The
400 m walk has been shown to be reliable and signifi-
cantly associated with measured maximal oxygen con-
sumption in middle-aged women[21].
Bone mineral density and body composition
BMI was calculated from height and weight measured
with a stadiometer and calibrated balance beam scale by
dividing the participant's weight in kilograms by the
square of her height in meters. Average WC was mea-
sured at the navel (horizontal plane at the center of the
navel) using a fiberglass retractable tape measure. A
Hologic QDR 4500 W densiometer (Hologic, Inc.; Bed-
ford, MA) was used to ascertain total hip, femoral neck,
and whole body areal bone mineral density (BMD, g/
cm2). Lumbar spine BMD was determined from the sub-
regional lumbar spine BMD in the whole-body scan.
Total bone mineral-free lean and total fat mass were also
derived from the whole-body scan. Dual energy x-ray
absorptiometry (DXA) quality assurance measurements
were conducted to ensure scanner reliability.
Cardiovascular disease risk factors
Total cholesterol, high density lipoprotein cholesterol
(HDL-c), triglycerides, and glucose were determined by
conventional methods. LDL-c was estimated by the Frie-
dewald equation and insulin was measured via radioim-
munoassay. Blood pressure was measured using a pulse-
obliteration procedure. Briefly, prior to blood pressure
measurement, the participant's arm was measured for
appropriate cuff size. Participants then sat quietly in a
room for 5 minutes with both feet flat on the floor and
then pulse-obliteration pressure was obtained. The cuff
was then inflated to a level of approximately 40 mmHg
above the pulse-obliteration level and deflated at a rate of
2 mmHg per s while listening for Korotkoff sounds. After
a brief period, blood pressure was taken a second time
and the average of the two readings was recorded.
Statistical methods
Univariate analyses were conducted on all relevant mea-
sured parameters. All variables were assessed for normal-
ity and examined for potential outliers. When examining
the distributions of the variables, self-reported physical
activity and insulin levels each had two leverage points
that were deemed outliers and removed from the analy-
ses. Normally distributed variables were reported as
mean and standard deviation, non-normal data as medi-
ans with interquartile range, and proportions were noted
for categorical variables. Differences in measured param-
eters between randomized groups were evaluated using
Student t-tests, Wilcoxon Rank Sum, chi square (χ2) or
Fisher's exact tests.
Study objective #1: comparison of physical activity data 
obtained using 60s vs. 10s epochs
Paired t-tests were used to compare the physical activity
estimates by epoch interval utilized. The agreement
between categories (i.e., quartiles) of physical activity
estimates and meeting versus not meeting 2008 Physical
Activity Guidelines, defined as 150 min/wk of MVPA [22],
expressed as 60 and 10s epochs were then evaluated using
Kendall's tau -b with 95% confidence intervals.
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research setting
Scatterplots between accelerometer-derived physical
activity estimates and health outcomes were examined
for linearity and Pearson's product-moment correlation
coefficients were used to describe the linear relationship
between health outcomes and accelerometer-determined
data presented as 10 and 60s epochs[23]. Hypothesis tests
for dependent correlations were performed to determine
whether the strength of the relationships between health
outcome and physical activity varied by epoch
length[24,25]. Linear mixed models (i.e., repeated mea-
sures regression) were used to quantify the rate of
increase or decrease in health outcome per unit increase
in physical activity for 10 and 60s epochs. Tests of equal-
ity between the two slopes were then computed to deter-
mine if measuring the rate of increase or decrease in
health outcome differed based on epoch length[26]. Cor-
relation coefficients, including tests evaluating the differ-
ence in strength of correlations[25], and regression
models were repeated after additional adjustment for
BMI for all health outcomes except for anthropometric
measures due to high colinearity. All statistical analyses
were generated using SAS/STAT software, Version 9.2 of
the SAS System for Windows (Cary, NC).
Results
A total of 508 women met the eligibility criteria for the
study and were randomized to either the health educa-
tion or lifestyle change group using a block randomized
design. Of the 508, 454 participants completed the clinic
portion of the 48 month follow-up visit. At this visit, 257
women were randomly approached to take part in an
accelerometer sub-study; of which 102 (39.7%) agreed to
participate. When compared to women who were not
part of the accelerometer sub-study, women who wore
the accelerometer had significantly lower BMI [29.0 (3.9)
vs. 30.5 (4.3) kg/m2; P = 0.0008] and average WC [98.1
(11.0) vs. 100.9 (11.6) cm; P = 0.03] and higher self-
reported leisure physical activity [15.9 (9.0, 24.3) vs. 10.8
(5.0, 19.6) MET•hr•wk-1; P = 0.0005] at the 48 month fol-
low-up visit.
The characteristics of the study participants are pre-
sented in Table 1. The mean age of participants included
in this report at the 48 month follow-up was 61.0 (2.8)
years and most were white, non-smokers, and achieved at
least a high school degree. Few differences were noted in
demographic factors, anthropometrics, accelerometer-
derived physical activity, or health outcomes between
randomized groups at the 48 month follow-up visit.
However, women in the lifestyle change group had higher
self-reported leisure physical activity, lower BMI and
insulin, and fewer initiated lipid lowering therapy when
compared to the health education group (all P < 0.05). It
Table 1: Participant characteristics in the Women on the 
Move through Activity and Nutrition (WOMAN) Study (n = 
102).
WOMAN Study 
Participants
Demographic Factors
Age at 48 month visit, years 61.0 (2.8)
High school graduate, % 98.0
Non-White, % 5.9
Married, % 66.7
Current smoker at 48 month visit, % 1.0
Medication Use at 48 month visit, %
Hormone therapy 16.7
Lipid lowering therapy 10.8
Hypertensive therapy 38.2
Hypoglycemic therapy 1.0
Anthropometric Measures
Body weight, lbs 169.7 (25.7)
Body Mass Index, kg/m2 29.0 (3.9)
Waist Circumference, cm 98.1 (11.0)
Whole body fat mass, kg 30.9 (6.9)
Trunk fat mass, kg 14.6 (3.9)
Whole body lean mass, kg 45.6 (5.5)
Trunk lean mass, kg 22.4 (2.8)
Bone Parameters
Spine, g/cm2 0.99 (0.14)
Trochanter, g/cm2 0.70 (0.11)
Intertrochanter, g/cm2 1.09 (0.14)
Femoral Neck, g/cm2 0.78 (0.10)
Hip, g/cm2 0.92 (0.12)
Physical Activity
Leisure Physical Activity, MET•hr•wk-1 15.7 (9.0, 24.2)
400 m walk, s 306.7 (39.8)
Cardiovascular Disease Risk Factors
Systolic Blood Pressure, mmHg 122.0 (116.0, 134.0)
Diastolic Blood Pressure, mmHg 78.0 (8.1)
Total Cholesterol, mg/dL 215.6 (33.6)
LDL-c, mg/dL 125.0 (30.7)
HDL-c, mg/dL 64.6 (53.6, 77.6)
Triglycerides, mg/dL 107.0 (82.0, 152.0)
Insulin, mg/dL 12.8 (4.7)
Glucose, mg/dL 102.1 (10.6)
Continuous data presented as mean (standard deviation) or median 
(interquartile range); categorical data as proportions (%).
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approximately 36 months; therefore, it is not surprising
that the randomized groups were similar at 48 months.
Accordingly, the following results are presented in the full
sample.
Study objective #1: comparison of physical activity data 
obtained using 60 vs. 10s epochs
WOMAN Study participants wore the ActiGraph accel-
erometer for 865.2 (70.9) min/d and average physical
activity volume was 315.7 (114.4) ct/min/d. Table 2 pres-
ents descriptive accelerometer data expressed as 60 and
10s epochs for physical activity summary estimates that
included every minute above a threshold level as well as
time spent in bouts of MVPA lasting at least 8 of 10 min-
utes (i.e., modified 10 minute bout)[3]. The absolute dif-
ference in physical activity estimates by epoch interval is
also presented. When compared to physical activity esti-
mates derived using 60s epochs, the mean time spent per
day in inactivity, moderate- and vigorous-intensity physi-
cal activity were significantly higher and light-intensity
physical activity was significantly lower when the 10s
sampling interval was utilized (all P < 0.001).
To reframe the results presented in Table 2, agreement
between quartiles of physical activity, as well as meeting
vs. not meeting current physical activity recommenda-
tions, presented as 60 or 10s epochs was examined (Table
3). The Kendall's tau-b statistic was strongest with inac-
tivity (adjusted for wear time) and weakest with moderate
intensity physical activity (0.90 and 0.85, respectively).
The median and 25th and 75th percentile values for vigor-
ous intensity physical activity expressed as 60s epochs
were zero; therefore, agreement with equivalent catego-
ries of 10s data could not be computed. Twenty-seven
(26.5%) participants were classified as meeting physical
activity guidelines using 10s, but not 60s, estimates of
MVPA. No (0%) participants were categorized as meeting
guidelines with 60s estimate of MVPA that were not also
classified in this manner using 10s epoch data. The
remaining participants were categorized similarly regard-
less of whether 10 or 60s epoch data was utilized [Kendall
tau-b: 0.53 (0.42, 0.65)].
Study objective #2: evaluation of physical activity-health 
outcome relationships by epoch length
Regardless of the time sampling interval used, physical
inactivity, adjusted for wear time, was inversely related to
self-reported leisure physical activity and directly related
to insulin levels (both P < 0.05), with no other significant
relationships noted (Table 4). The correlation between
self-reported physical activity and inactivity was signifi-
cantly stronger with data collected as 10s epochs (P <
0.01); however, the regression slope between health out-
come and inactivity expressed as 60 vs. 10s epochs were
not statistically different. After additional adjustment for
BMI, results were similar. However, only the correlation
between physical inactivity estimate, captured via 60s
epochs, and glucose and HDL-c was statistically signifi-
cant (all P < 0.05). Similar to the unadjusted results, the
correlation between past year reported physical activity
and physical inactivity adjusted for BMI was significantly
stronger with data collected as 10s epochs (P = 0.04);
however, the regression slopes were not significantly dif-
ferent (data not shown). (NOTE: refer to Additional file
1)
Regardless of epoch length, MVPA was inversely asso-
ciated with anthropometric measures including BMI,
waist circumference, and whole body and trunk fat (all P
< 0.05) (Table 5). MVPA collected every 60s was also sig-
nificantly related to body weight, whole body and trunk
lean mass (all P < 0.05), whereas the correlation between
these anthropometric measures and 10s data were either
borderline statistically significant or null. MVPA pre-
sented for both 60 and 10s epochs was also directly asso-
ciated with spine BMD (both P < 0.05), self-reported past
year physical activity (both P < 0.001) and inversely
related to 400 m walk time (both P < 0.001), insulin (both
P < 0.001), and glucose (both P < 0.05). MVPA collected
in 10s epochs was also inversely related to systolic BP (P <
0.05); whereas, the relationship was not statistically sig-
nificant when reintegrated to 60s data. The correlation
between MVPA and body weight, BMI, whole body and
trunk fat and lean mass were significantly stronger with
data expressed using a 60s epoch when compared to the
10s data (all P < 0.05). However, there was no difference
in correlation strength by epoch length with spine BMD,
self-reported leisure physical activity, time taken to com-
plete the 400 m walk, insulin or glucose collected at the
48 month follow-up visit. When examining the equality
of the regression slopes between health outcome and
MVPA by epoch interval, no significant differences were
noted. Results were similar after additional adjustment
for BMI; however, MVPA was no longer significantly
associated with systolic BP or glucose. Finally, the associ-
ation between triglycerides and MVPA was significantly
stronger when expressed as 60s epochs; however, similar
to the unadjusted results, there were no differences in
slopes between 60 and 10s data for any health outcome
(data not shown). (NOTE: refer to Additional file 2)
Discussion
In the current investigation, accelerometer-derived physi-
cal activity estimates and relationships with health out-
comes were compared by length of time sampling interval
(i.e., 60s vs. 10s epoch). Findings suggest that although
there was a significant difference in physical activity esti-
mates by epoch length, the relationship between physical
activity and most health outcomes did not vary by length
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2010, 7:53
Page 6 of 10of data collection. There were, however, a few health out-
comes that were more strongly correlated with MVPA
presented as 60s epochs when compared to 10s epoch-
derived estimates. This finding may relate to the underly-
ing role of physical activity in the causation of obesity
such that 60s estimates may better reflect total energy
expenditure. However, when examining the equality of
the regression slope in these variables by epoch length, no
significant differences in relationships were noted. This
suggests that measuring the rate of change in health out-
comes as a function of physical activity is not dependent
on the length of data collection based on current process-
ing methods. Further, additional adjustment for BMI did
not elicit strikingly different findings when compared
with the unadjusted results.
The current study is not the first to observe differences
of intensity classification based on epoch length, but
builds upon previous research that was limited to chil-
dren and adolescents[27-29]. Given the nature and pri-
mary purpose of the WOMAN Study, a criterion measure
of physical activity was not included for additional com-
parison of study findings. Regardless, several key sources
of error in physical activity outcomes based on 60s data
are worthy of noting. First, intermittent activities are eas-
ily misclassified, with brief moderate intensity activities
often categorized as light intensity once data are summed
over a full minute. Similarly, brief periods of movement
can result in misclassification of predominately sedentary
minutes as light intensity. Second, sustained bouts of
activity lasting at least 60s rarely start and stop in syn-
chronization with the accelerometer's internal clock. As a
result, a 60s bout of walking, or the beginning and end of
a longer walking bout, can easily be split over more than
one 60s interval, which could result in misclassification of
moderate activities as light intensity. These sources of
misclassification can result in substantial shifts between
60 and 10s epoch for minutes detected as light vs. inac-
tive and smaller, but important, shifts between minutes
detected as light vs. MVPA. Perhaps most striking is the
transfer of roughly 100 min/d detected as light intensity
based on 60s epochs to inactive minutes, raising the pro-
portion of inactive or sedentary time from 60% to 72% of
monitored time, or an additional 1 hour and 39 minutes
of sedentary time per day among these women. Under-
standing the role that epoch length has in defining physi-
cal activity estimates is of critical importance in order to
reduce sources of systematic error in research studies.
It is important to note that physical activity estimates
were derived from activity count threshold-based pro-
cessing methods that have been used almost exclusively
by researchers over the past decade[1]. However,
advancements in accelerometer technology have
enhanced the level of sophistication of available data pro-
cessing methods and interpretation of derived summary
estimates. Early efforts by Crouter et al., utilized a two
regression approach that predicted intensity from sepa-
rate equations based on the variability of the detected
activity sampled in 10s epochs[30,31]. However, as previ-
ously stated, the ActiGraph and other devices are now
capable of sampling data using 1s epochs or in raw accel-
eration mode to provide a dense data stream for use in
emerging signal processing and pattern recognition mod-
els (e.g., artificial neural networks)[2,32]. Recent progress
in accelerometer processing methods offer promise for
increased accuracy of physical activity estimates from
body worn accelerometers; precision that could poten-
Table 2: Accelerometer data† expressed using 60 and 10 second (s) epoch intervals in WOMAN Study Participants at the 48 
month follow-up visit (n = 102).
60s epoch 10s epoch Δ†† t-value
Mean (SD) Range Mean (SD) Range
Inactivity: wear time††† .60 (0.08) .36 - .79 .72 (0.07) .50 - .86 -.11 (0.02) -50.3*
Inactivity (0-99 ct), min/day 523.4 (79.0) 351.2 - 702.9 622.8 (71.2) 449.2 - 765.5 -99.4 (22.4) -44.9*
Light Intensity (100-<2020 ct), min/day 315.0 (74.2) 167.1 - 572.9 200.1 (51.8) 98.8 - 388.8 114.9 (27.0) 43.0*
Moderate Intensity (2020-<5999 ct), min/day 26.1 (19.6) .28 - 92.4 41.2 (21.7) 3.7 - 107.0 -15.0 (5.9) -25.5*
Vigorous Intensity (≥5999 ct), min/day .7 (2.8) .05 - 15.7 1.2 (3.0) .04 - 17.9 -.5 (0.63) -8.1*
MVPA (≥2020 ct), min/day 26.9 (20.1) .28 - 92.9 42.4 (22.4) 3.8 - 109.5 -15.5 (6.1) -25.8*
Activity Bouts of MVPA (≥2020 ct), min/day 14.6 (16.3) 0 - 70.4 14.6 (16.3) 0 - 70.4 --- ---
†Data presented as mean (standard deviation)
††Δ calculated as the difference between the mean time spent per day in a given intensity level using a 60 second epoch interval (i.e., current 
practice) minus the average time spent per day in a given intensity level using a 10 second epoch interval and then averaged for all participants.
†††Presented as the ratio between inactivity and wear time.
*Paired t-tests were used to test the hypothesis of no difference in physical activity summary estimates between ActiGraph data collected as 10 
or 60 second epochs; P < 0.0001
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ships with health outcomes beyond those observed in the
current study. In the current report, accelerometer data
was sampled using 10s epochs in order to utilize data pro-
cessing methods that were available at the time the 48
month follow-up visits were initiated. It is important to
note that these results were gleaned from 2 epoch lengths
and examined in a specific population sub-group. How-
ever, since high frequency accelerometer data can be
reintegrated to a lower resolution, as was done in the cur-
rent report (i.e., 10s to 60s epochs), with no additional
burden, we would encourage researchers to collect data at
the maximum allowable resolution for the desired moni-
toring period in order to preserve the ability to utilize the
latest advancements in accelerometer data processing
methods for use in epidemiological studies as they
become available.
When interpreting the findings, several limitations
need to be considered. Given the cross-sectional nature
of the data, no inferences should be made about the cau-
sality of relationships between physical activity and
health outcomes. Due to limited resources, accelerometer
data was only collected in one-quarter of WOMAN Study
participants who attended the 48 month follow-up visit.
Although collecting accelerometer data in all participants
attending the 48 month follow-up visit would have
increased the power to see more significant physical
activity-health outcome relationships, few differences
were noted between those who were included in the
accelerometer sub-study and those who were not. Finally,
waist-worn, uni-axial accelerometers provide an accurate
measure of predominantly ambulatory activities and,
thus, do not capture all physical activities that may con-
tribute to an improvement in health outcomes[3]. Fur-
thermore, comparisons with self-reported leisure
physical activity may also be limited as the past-year
MAQ includes non-ambulatory activities, but not lower
intensity activities (i.e., household chores), which may be
captured with accelerometers. Therefore, the weak or
null relationships between health outcome and physical
activity that were observed in the current study may be a
reflection of the limited quantification of total physical
activity or simply the result of the relatively homogeneous
nature of the study sample.
Conclusions
In summary, findings from the current report suggest
that although the use of a shorter time sampling interval
may suggestively reduce misclassification error of physi-
cal activity estimates, the estimates did not elicit strik-
ingly different associations with health outcomes. These
results have important public health implications, partic-
ularly for researchers who might not have the current
resources available to replace first generation accelerom-
eters with newer models that are equipped with
enhanced memory capacity. Our findings suggest that
accelerometer data collected over longer epoch intervals
provides meaningful physical activity estimates that
relate well to a comprehensive portfolio of diverse and
clinically-meaningful health outcomes and validates the
findings of earlier studies that were limited to use of a 60s
epoch. Since data was obtained from a select population
of overweight, healthy, post-menopausal women, we
would like to encourage future studies to examine these
important questions in their own study populations to
further our understanding of the extent to which epoch
length contributes to the ascertainment of physical activ-
ity in research studies.
Table 3: Agreement between quartiles of accelerometer data† expressed using 60 and 10 second (s) epoch intervals 
collected in WOMAN Study Participants at the 48 month follow-up visit (n = 102).
Kendall's tau-b 95% Confidence Limits
Inactivity: wear time 0.90 0.86, 0.95
Inactivity (0-99 ct), min/day†† 0.88 0.82, 0.93
Light Intensity (100-<2020 ct), min/day 0.87 0.82, 0.92
Moderate Intensity (2020-<5999 ct), min/day 0.85 0.79, 0.90
Vigorous Intensity (≥5999 ct) †, min/day --- ---
MVPA (≥2020 ct), min/day 0.86 0.80, 0.91
Quartile ranges created using median (interquartile range) that are presented in table 1 for light-, moderate-, vigorous, and moderate- to 
vigorous- intensity physical activity. Quartile ranges for inactivity were <471.6, ≥471.6-<527.4, ≥527.4-<580.1, and ≥580.1 for 60 second 
epoch data and <583.5, ≥583.5-<632.1, ≥632.1-<665.8, and ≥665.8 for 10 second epoch data.
†Unable to compute, median (IQR) for vigorous- intensity physical activity collected in 60s epochs was 0 (0.0, 0.0)
††Presented as the ratio between inactivity and wear time.
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Table 4: Relationship between inactivity [adjusted for wear time (min/day)] accumulated in 60 and 10 second epochs and 
health outcome measures (n = 102).
60s epoch 10s epoch Test for 
Difference 
Between 
Correlations p 
value
60s epoch β 10s epoch β Test for Equality 
of Slope p value
ρ ρ
Anthropometric Measures
Body weight, lbs -0.077 -0.077 0.98 -0.0003 -0.0002 0.56
Body Mass Index, kg/m2 -0.073 -0.055 0.40 -0.0015 -0.0009 0.30
Waist Circumference, cm 0.053 0.042 0.61 0.0004 0.0003 0.49
Whole body fat mass, kg -0.011 0.014 0.24 -0.0001 0.0001 0.44
Trunk fat mass, kg 0.030 0.056 0.24 0.0000 0.0000 ---
Whole body lean mass, kg -0.037 -0.038 0.97 -0.0000 -0.0000 ---
Trunk lean mass, kg -0.008 -0.006 0.93 -0.0000 -0.0000 ---
Bone Parameters
Spine, g/cm2 -0.006 0.009 0.48 -0.0036 0.0041 0.64
Trochanter, g/cm2 -0.033 -0.047 0.51 -0.0244 -0.0277 0.88
Intertrochanter, g/cm2 0.003 0.009 0.77 0.0019 0.0044 0.88
Femoral Neck, g/cm2 -0.100 -0.092 0.70 -0.0781 -0.0568 0.33
Hip, g/cm2 -0.015 -0.013 0.92 -0.0108 -0.0074 0.86
Physical Activity
Leisure Physical Activity, MET•hr•wk-1 b -0.255* -0.302** 0.03 -0.0014** -0.0013*** 0.51
400 m walk, s d 0.031 0.048 0.43 0.0001 0.0001 0.80
Cardiovascular Disease Risk Factors
Systolic Blood Pressure, mmHg 0.028 0.039 0.60 0.0002 0.0002 0.92
Diastolic Blood Pressure, mmHg -0.016 -0.008 0.70 -0.0002 -0.0001 0.72
Total Cholesterol, mg/dL a -0.179† -0.161 0.39 -0.0004† -0.0003 0.07
LDL-c, mg/dL a -0.123 -0.099 0.26 -0.0003 -0.0002 0.12
HDL-c, mg/dL a -0.154 -0.148 0.76 -0.0008 -0.0006 0.18
Triglycerides, mg/dL a 0.036 0.014 0.30 0.0001 0.0000 0.38
Insulin, mg/dL c 0.212* 0.224* 0.57 0.0036* 0.0030* 0.23
Glucose, mg/dL a 0.182† 0.166† 0.45 0.0014† 0.0010† 0.07
†P < 0.10; *P < 0.05; **P < 0.01; ***P < 0.001; a n = 101; b n = 100; c n = 99; d n = 90
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Table 5: Relationship between moderate- to vigorous- intensity physical activity (min/day) accumulated in 60 and 10 
second epochs and health outcome measures (n = 102).
60s epoch 10s epoch Test for 
Difference 
Between 
Correlations p 
value
60s epoch β 10s epoch β Test for Equality 
of Slope p value
ρ ρ
Anthropometric Measures
Body weight, lbs -0.231* -0.165† 0.01 -0.18* -0.14† 0.12
Body Mass Index, kg/m2 -0.253* -0.202* 0.05 -1.30* -1.16* 0.36
Waist Circumference, cm -0.286** -0.273** 0.59 -0.52** -0.55** 0.55
Whole body fat mass, kg -0.334*** -0.251* 0.001 -0.96 -0.81 0.07
Trunk fat mass, kg -0.347*** -0.286** 0.01 -1.76 -1.63 0.37
Whole body lean mass, kg -0.198* -0.136 0.02 -0.72* -0.55 0.13
Trunk lean mass, kg -0.228* -0.177† 0.05 -1.64* -1.42† 0.32
Bone Parameters
Spine, g/cm2 -0.270** -0.253* 0.51 -38.58** -40.37* 0.68
Trochanter, g/cm2 -0.075 -0.045 0.27 -13.70 -9.27 0.43
Intertrochanter, g/cm2 -0.110 -0.083 0.31 -16.31 -13.75 0.57
Femoral Neck, g/cm2 -0.122 -0.063 0.02 -23.31 -13.43 0.09
Hip, g/cm2 -0.113 -0.080 0.20 -19.57 -15.37 0.42
Physical Activity
Leisure Physical Activity, 
MET•hr•wk-1 b
0.336*** 0.335*** 0.97 0.45*** 0.51*** 0.18
400 m walk, s d -0.437*** -0.415*** 0.40 -0.22*** -0.23*** 0.45
Cardiovascular Disease Risk Factors
Systolic Blood Pressure, mmHg -0.169† -0.203* 0.19 -0.22† -0.29* 0.06
Diastolic Blood Pressure, mmHg -0.101 -0.115 0.62 -0.25 -0.32 0.38
Total Cholesterol, mg/dL a 0.042 0.055 0.64 0.03 0.04 0.53
LDL-c, mg/dL a 0.006 0.030 0.38 0.004 0.02 0.38
HDL-c, mg/dL a 0.105 0.115 0.70 0.13 0.16 0.44
Triglycerides, mg/dL a -0.040 -0.085 0.09 -0.01 -0.04 0.07
Insulin, mg/dL c -0.307** -0.289** 0.49 -1.29** -1.35** 0.66
Glucose, mg/dL a -0.212* -0.213* 0.99 -0.40* -0.45* 0.41
†P < 0.10; *P < 0.05; **P < 0.01; ***P < 0.001; a n = 101; b n = 100; c n = 99; d n = 90
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